109 related articles for article (PubMed ID: 22575449)
1. Proteasomal insensitivity of apoptin in tumor cells.
Lanz HL; Suijker J; Noteborn MH; Backendorf C
Biochem Biophys Res Commun; 2012 May; 422(1):169-73. PubMed ID: 22575449
[TBL] [Abstract][Full Text] [Related]
2. Differential sensitivity of breast cancer and melanoma cells to proteasome inhibitor Velcade.
Yerlikaya A; Erin N
Int J Mol Med; 2008 Dec; 22(6):817-23. PubMed ID: 19020781
[TBL] [Abstract][Full Text] [Related]
3. Development and application of an in vitro apoptin kinase assay.
Lanz HL; Florea BI; Noteborn MH; Backendorf C
Anal Biochem; 2012 Feb; 421(1):68-74. PubMed ID: 22080040
[TBL] [Abstract][Full Text] [Related]
4. Effect of noncompetitive proteasome inhibition on bortezomib resistance.
Li X; Wood TE; Sprangers R; Jansen G; Franke NE; Mao X; Wang X; Zhang Y; Verbrugge SE; Adomat H; Li ZH; Trudel S; Chen C; Religa TL; Jamal N; Messner H; Cloos J; Rose DR; Navon A; Guns E; Batey RA; Kay LE; Schimmer AD
J Natl Cancer Inst; 2010 Jul; 102(14):1069-82. PubMed ID: 20505154
[TBL] [Abstract][Full Text] [Related]
5. Activity patterns of proteasome subunits reflect bortezomib sensitivity of hematologic malignancies and are variable in primary human leukemia cells.
Kraus M; Rückrich T; Reich M; Gogel J; Beck A; Kammer W; Berkers CR; Burg D; Overkleeft H; Ovaa H; Driessen C
Leukemia; 2007 Jan; 21(1):84-92. PubMed ID: 17024115
[TBL] [Abstract][Full Text] [Related]
6. Increased expression and altered subunit composition of proteasomes induced by continuous proteasome inhibition establish apoptosis resistance and hyperproliferation of Burkitt lymphoma cells.
Fuchs D; Berges C; Opelz G; Daniel V; Naujokat C
J Cell Biochem; 2008 Jan; 103(1):270-83. PubMed ID: 17516511
[TBL] [Abstract][Full Text] [Related]
7. [Molecular mechanism of specific induction of apoptosis in tumor cells by apoptin].
Wang QM; He FC
Ai Zheng; 2005 Apr; 24(4):509-12. PubMed ID: 15820081
[TBL] [Abstract][Full Text] [Related]
8. Apoptin: therapeutic potential of an early sensor of carcinogenic transformation.
Backendorf C; Visser AE; de Boer AG; Zimmerman R; Visser M; Voskamp P; Zhang YH; Noteborn M
Annu Rev Pharmacol Toxicol; 2008; 48():143-69. PubMed ID: 17848136
[TBL] [Abstract][Full Text] [Related]
9. Evidence that mitogen-activated protein kinase phosphatase-1 induction by proteasome inhibitors plays an antiapoptotic role.
Small GW; Shi YY; Edmund NA; Somasundaram S; Moore DT; Orlowski RZ
Mol Pharmacol; 2004 Dec; 66(6):1478-90. PubMed ID: 15448190
[TBL] [Abstract][Full Text] [Related]
10. Amino acid starvation sensitizes cancer cells to proteasome inhibition.
Mizrachy-Schwartz S; Cohen N; Klein S; Kravchenko-Balasha N; Levitzki A
IUBMB Life; 2010 Oct; 62(10):757-63. PubMed ID: 20931634
[TBL] [Abstract][Full Text] [Related]
11. TAT-apoptin is efficiently delivered and induces apoptosis in cancer cells.
Guelen L; Paterson H; Gäken J; Meyers M; Farzaneh F; Tavassoli M
Oncogene; 2004 Feb; 23(5):1153-65. PubMed ID: 14691460
[TBL] [Abstract][Full Text] [Related]
12. MDA-7/IL-24, a novel tumor suppressor/cytokine is ubiquitinated and regulated by the ubiquitin-proteasome system, and inhibition of MDA-7/IL-24 degradation enhances the antitumor activity.
Gopalan B; Shanker M; Scott A; Branch CD; Chada S; Ramesh R
Cancer Gene Ther; 2008 Jan; 15(1):1-8. PubMed ID: 17828282
[TBL] [Abstract][Full Text] [Related]
13. Apoptin acts as a tumor-specific killer: potentials for an anti-tumor therapy.
Noteborn MH
Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(1):49-60. PubMed ID: 16171564
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic window for melanoma treatment provided by selective effects of the proteasome on Bcl-2 proteins.
Wolter KG; Verhaegen M; Fernández Y; Nikolovska-Coleska Z; Riblett M; de la Vega CM; Wang S; Soengas MS
Cell Death Differ; 2007 Sep; 14(9):1605-16. PubMed ID: 17541428
[TBL] [Abstract][Full Text] [Related]
15. HSPA9 overexpression inhibits apoptin-induced apoptosis in the HepG2 cell line.
Peng C; Yang P; Cui Y; He M; Liang L; Di Y
Oncol Rep; 2013 Jun; 29(6):2431-7. PubMed ID: 23589050
[TBL] [Abstract][Full Text] [Related]
16. Modulation of ceramide metabolism enhances viral protein apoptin's cytotoxicity in prostate cancer.
Liu X; Elojeimy S; El-Zawahry AM; Holman DH; Bielawska A; Bielawski J; Rubinchik S; Guo GW; Dong JY; Keane T; Hannun YA; Tavassoli M; Norris JS
Mol Ther; 2006 Nov; 14(5):637-46. PubMed ID: 16887394
[TBL] [Abstract][Full Text] [Related]
17. The proteasome inhibitor bortezomib acts independently of p53 and induces cell death via apoptosis and mitotic catastrophe in B-cell lymphoma cell lines.
Strauss SJ; Higginbottom K; Jüliger S; Maharaj L; Allen P; Schenkein D; Lister TA; Joel SP
Cancer Res; 2007 Mar; 67(6):2783-90. PubMed ID: 17363600
[TBL] [Abstract][Full Text] [Related]
18. Apoptin T108 phosphorylation is not required for its tumor-specific nuclear localization but partially affects its apoptotic activity.
Lee YH; Cheng CM; Chang YF; Wang TY; Yuo CY
Biochem Biophys Res Commun; 2007 Mar; 354(2):391-5. PubMed ID: 17223075
[TBL] [Abstract][Full Text] [Related]
19. Apoptin, a protein derived from chicken anemia virus, induces p53-independent apoptosis in human osteosarcoma cells.
Zhuang SM; Shvarts A; van Ormondt H; Jochemsen AG; van der Eb AJ; Noteborn MH
Cancer Res; 1995 Feb; 55(3):486-9. PubMed ID: 7834613
[TBL] [Abstract][Full Text] [Related]
20. The viral protein Apoptin induces apoptosis in UV-C-irradiated cells from individuals with various hereditary cancer-prone syndromes.
Zhang YH; Abrahams PJ; van der Eb AJ; Noteborn MH
Cancer Res; 1999 Jun; 59(12):3010-5. PubMed ID: 10383168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
